Discover where $40+ billion flowed in the first half of 2025.
Our exclusive report breaks down the biggest biotech & pharma funding trends — from record-breaking mega-rounds to AI-driven breakthroughs, late-stage rebounds, and early-stage bottlenecks. Clear insights for business development, sales, and strategy teams who need to know who’s winning capital — and what that means for 2025 and beyond.

​

Be the first to get the full funding report in your inbox.
Submit your email and we’ll deliver the full report straight to your

inbox the moment it goes live.